Occam Crest Management LP

Position in GHRS — GH Research PLC

CIK 2085909 Darien, CT

Position in GHRS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,124,800

New position

Shares Held

80,000

first reported quarter

Ownership

0.117%

of shares outstanding

% of Portfolio

0.71%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Occam Crest Management LP holds $59,155,147 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	TGTX	Tg Therapeutics, Inc.	425,000	$23,349,500
2	PGEN	Precigen, Inc.	3,605,941	$20,553,863
3	AXSM	Axsome Therapeutics, Inc.	29,800	$7,294,146
4	NVCT	Nuvectis Pharma, Inc.	357,147	$6,567,933
5	IMRX	Immuneering Corp	278,498	$1,389,705

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,124,800	80,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.